Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
    • Our Story
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach.

Events, Media & Press
The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach”, organized by Foment del Treball.Foment del Treball

On Tuesday, Wednesday 29, our CEO, Meritxell Teixidó, will participate in the session “The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach”, organized by Foment del Treball.

The aim of this event is to address issues such as the future of research and innovation, the strengthening of drug production, security and strategic autonomy, through the participation and debate of institutional representatives, experts, professionals and biopharmaceutical companies.

An opportunity to create a constructive dialogue between the actors of the biopharmaceutical sector by sharing knowledge, experiences and opinions to promote innovation, which results in the improvement of health care, economic development and the well-being of the population.

➡️ Register here

March 23, 2023/by noticias
Tags: biopharmaceutical, FomentdelTreball, Gate2Brain
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2023/03/Captura-de-pantalla-2023-03-23-a-las-8.43.58.png 942 1248 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2023-03-23 08:54:152025-02-19 09:35:26The innovative biopharmaceutical industry, a lever for economic and social well-being. A comprehensive approach.
You might also like
Gate2Brain abre una ronda puenteo de un millón de euros para ensayos preclínicoPlantaDoceGate2Brain opens one million euro bridge round for preclinical trials
Innovation & Scalability for the new generationsInnovation & Scalability for the new generations
Patil Bhalchandra – Meet the Team
Womenstartupawardsgate2BrainWomenStarUpAwards
Within the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell Teixidó, and the first and only APS American Peptide Idol joined @CEM's Dr. Wendy Hartsock to discuss the work @Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.CEMExploration Science with Dr. Wendy Harsock
Gate2Brain and its “molecular tractors” technology: new way to optimize the transport of drugs to the brain
Every milestone matters. Together, they shaped our journey.
Gate2Brain at TransfiereG2BG2B at Transfiere 2023

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain Selected for the EU Business Hub Mission at World Health Expo Osaka 2026June 23, 2026 - 13:31
  • Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025November 3, 2025 - 10:23
  • Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery SolutionsOctober 15, 2025 - 12:56
  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Technology closer to young patientsTechnology closer to young patientsG2BCataloniaBio & Health Teach GalaG2BCataloniaBio HT Gala 2023
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}